David Drutz, Director at Altimmune, Inc. (ALT), bought 300 shares at $2.88 ($864) on 2023-08-15, disclosed to the SEC on 2023-08-15.
Open-market purchase of $864 ALT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| ALT | BUY | 2022-06-16 | $8K | — | Filing → |
| ALT | BUY | 2022-05-25 | $5K | — | Filing → |
| ALT | BUY | 2017-08-24 | $22K | — | Filing → |